Bristol Myers Squibb (CELG-RI) Profit After Tax (QoQ) (2009 - 2026)

Bristol Myers Squibb (CELG-RI) Profit After Tax (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 147.05%
Dec 31, 2025 -50.75%
Sep 30, 2025 109,950.00%
Jun 30, 2025 -99.92%
Mar 31, 2025 3,936.07%
Dec 31, 2024 -94.98%
Sep 30, 2024 -27.68%
Jun 30, 2024 114.10%
Mar 31, 2024 -775.99%
Dec 31, 2023 -8.89%
Sep 30, 2023 48,250.00%
Jun 30, 2023 -20.00%
Mar 31, 2023 -99.75%
Dec 31, 2022 26.87%
Sep 30, 2022 13.16%
Jun 30, 2022 28,320.00%
Mar 31, 2022 -99.79%
Dec 31, 2021 54.72%
Sep 30, 2021 46.54%
Jun 30, 2021 -47.80%